The Competition Commission of India (CCI) has approved the acquisition of 100% equity shares of Medlife International Private Limited (“Medlife”) by API Holdings Private Limited (“API Holdings”). It also approved the acquisition of up to 19.59% equity share capital of API Holdings by Medlife’s shareholders under Section 31(1) of the Competition Act, 2002.
API is a private company, incorporated in 2019. API directly or through its subsidiaries carries out various business activities including wholesale sale and distribution of drugs; transportation and delivery services primarily focused on pharmaceutical sector; owning technology and intellectual property for developing e- commerce platforms. Medlife is primarily a healthcare company engaged in the wholesale sale and distribution of drugs.
Important takeaways for all competitive exams:
The Ministry of Health and Population of Nepal has urged residents to wear masks due…
In April 2024, India witnessed a historic milestone in its Goods and Services Tax (GST)…
India boasts a rich tapestry of cities, each weaving its own story of heritage, culture,…
China is set to launch the Chang'e-6 lunar probe on a round trip to the…
As travelers seek inspiration for their next adventure, the world offers a plethora of stunning…
Himachal Pradesh, nestled in the lap of the majestic Himalayas, is a paradise for nature…